Overview
- Berenberg published adjusted 2025 financial statements on July 21 that incorporate a forensic review and show a net profit of €20.2 million, with Deloitte issuing an unqualified audit opinion on the corrected accounts.
- The bank’s internal forensic investigation identified four discrete problems: internal rebookings that created profit effects without disposals, a sell-and-repurchase of a convertible with no economic transfer, premature recognition of gains on equity forwards, and questions over the substance of a disposal that affected regulatory capital.
- Germany’s regulator BaFin ordered the three managing directors to step aside on June 19 and installed Hans‑Walter Peters and Michael Horf as special commissioners who currently hold managerial authority.
- Berenberg says its regulatory capital and liquidity remained above required levels and that client business was not affected, while the supervisory board has pledged to strengthen oversight and control functions.
- The review found approval of 'Organkredite' — loans to members of management with limited market conformity — and a pattern of transactions aimed at steering capital and smoothing earnings, a dynamic that risks tighter regulation, legal scrutiny, and a prolonged governance overhaul at the bank.